Most Recent
Jones Day partner appointed Westpac’s new group GC
Westpac 2021-07-14 1:26 pm By Bianca Hrovat

A senior partner at Jones Day and member of the advisory committee to the Australian Law Reform Commission has been appointed Westpac’s new group general […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Judge tosses Caltex trade mark case, says Chevron does not own colour red
Intellectual Property 2021-06-08 9:57 pm By Miklos Bolza

Chevron has mostly failed in its lawsuit accusing Australian petrol station company Ampol of infringing its Caltex trade marks, with a judge finding that Chevron’s […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Judge warns ‘enough’s enough’ in fight for damages over delayed Abilify generic
Intellectual Property 2021-06-03 10:52 am By Cat Fredenburgh

A judge has given Generic Health more time to file its evidence in a multimillion-dollar dispute with drug makers Otsuka and Bristol-Myers Squibbs over the […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Jones Day lures top Perth litigator from rival US firm
People In The News 2021-05-12 2:19 pm By Cat Fredenburgh

US-based firm Jones Day has snagged one of Perth’s top energy litigators from rival Quinn Emanuel to bolster its global disputes team. Michael Lundberg joins […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Otzuka, Bristol-Myers lose discovery bid in decade-old fight over Abilify
Intellectual Property 2021-04-27 4:46 pm By Christine Caulfield

The companies behind the top selling Abilify medication have lost their latest bid for documents from the Commonwealth in a multimillion dollar dispute over the […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Ampol hits back at Chevron in trade mark trial over Caltex brand
Intellectual Property 2021-04-19 8:31 pm By Cindy Cameronne

Petrol station operator Ampol has denied accusations by US oil giant Chevron that it is misusing Caltex branding on 175 of its service stations, on […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Judge fast-tracks Chevron’s high stakes case against Ampol over Caltex trade mark
Intellectual Property 2021-01-15 2:35 pm By Miklos Bolza

A trade mark dispute between US oil giant Chevron and Australian petrol station operator Ampol has been set down for an expedited hearing in April, […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

GetSwift not ‘fleeing the jurisdiction’ with Canada relocation bid, court told
Corporate 2020-11-26 6:58 pm By Miklos Bolza

Logistics software company GetSwift has tried to assure the Federal Court that an attempt to relocate to Canada is not for the purpose of avoiding […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

GetSwift’s move to Canada wins court, FIRB approval after fierce opposition by ASIC
Securities 2021-01-08 9:21 pm By Miklos Bolza

Last-mile logistics software company GetSwift has ceased trading on the ASX after its relocation to Canada got the greenlight by the Federal Court and FIRB […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

Juno and Bristol-Myers Squibb suffer losses in Revlimid patent war
Intellectual Property 2021-03-25 1:58 pm By Miklos Bolza

A patent battle between Juno Pharmaceuticals and Bristol-Myers Squibb over the blockbuster drug Revlimid has seen both sides suffer early losses, with a judge dismissing […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.